Assessment of the Mechanism for Remdesivir-Associated Clinical ALT Elevations Using DILIsym Quantitative Systems Toxicology Modeling

Assessment of the Mechanism for Remdesivir-Associated Clinical ALT Elevations Using DILIsym Quantitative Systems Toxicology Modeling

Conference: AASLD
Software: DILIsym®

Remdesivir, a monophosphoramidate prodrug of a nucleoside analog, has been granted Emergency Use Authorization in the U.S. for the treatment of hospitalized COVID-19 patients.

In Silico Modeling as a Tool to Predict and Characterize Plant Toxicity

In Silico Modeling as a Tool to Predict and Characterize Plant Toxicity

Publication: Poisonous Plants and Phytochemicals in Drug Discovery
Software: ADMET Predictor®

One of the greatest challenges encountered during the manufacture of drugs is the high level of toxicity, which can have adverse effects on the environment, humans, plants, and animals.

Development of Quantitative Systems Toxicology Model to Predict Drug Induced Acute Kidney Injury via mtDNA Depletion Pathway

Development of Quantitative Systems Toxicology Model to Predict Drug Induced Acute Kidney Injury via mtDNA Depletion Pathway

Conference: ACoP
Software: GastroPlus®, RENAsym®

Treatment of chronic viral infections like HIV, Hepatitis B etc necessitates long term administration of powerful antivirals like...

Mechanistic Modeling of Cyclosporine A-induced Acute Kidney Injury with RENAsym®

Mechanistic Modeling of Cyclosporine A-induced Acute Kidney Injury with RENAsym®

Conference: ACoP
Software: RENAsym®

The use of Cyclosporine A (CsA) can cause tubular damage leading to a decline in renal function as determined by decreases in serum creatinine levels...

Modeling Insights on Species Differences in Response to CD8+ T cell-mediated Liver Injury

Modeling Insights on Species Differences in Response to CD8+ T cell-mediated Liver Injury

Conference: ACoP
Software: DILIsym®

Idiosyncratic drug-induced liver injury (iDILI), which is typically rare and often severe, has led to black box warnings or drug withdrawals from the market...

Mathematically modeling CD8+ T cell-mediated drug induced liver injury (DILI): from ovalbumin to amodiaquine in mice

Mathematically modeling CD8+ T cell-mediated drug induced liver injury (DILI): from ovalbumin to amodiaquine in mice

Conference: ACoP
Software: DILIsym®

Idiosyncratic drug-induced liver injury (iDILI) is poorlynunderstood, but there is evidence to support that some iDILI events may be immune-mediated.

Novel Synthesis and Antiviral Evaluation of New Benzothiazole-Bearing N-Sulfonamide 2-Pyridone Derivatives as USP7 Enzyme Inhibitors

Novel Synthesis and Antiviral Evaluation of New Benzothiazole-Bearing N-Sulfonamide 2-Pyridone Derivatives as USP7 Enzyme Inhibitors

Publication: ACS Omega
Software: ADMET Predictor®

In this article, a series of benzothiazole-bearing N-sulfonamide 2-pyridone derivatives were synthesized via the reaction of benzothiazole...